Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123830893 | 12383089 | 3 | F | 20160302 | 20160718 | 20160518 | 20160728 | EXP | US-ACTELION-A-NJ2016-133148 | ACTELION | 43.00 | YR | A | F | Y | 0.00000 | 20160728 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123830893 | 12383089 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 125 MG, BID | 21290 | 125 | MG | TABLET | BID | ||||||
123830893 | 12383089 | 2 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 3 | C | REMODULIN | TREPROSTINIL | 1 | 0 | ||||||||||||
123830893 | 12383089 | 4 | C | BUMETANIDE. | BUMETANIDE | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 5 | C | METOLAZONE. | METOLAZONE | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 6 | C | ULORIC | FEBUXOSTAT | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 7 | C | COLCHICINE. | COLCHICINE | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 8 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 9 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 10 | C | DIGOXIN. | DIGOXIN | 1 | U | 0 | |||||||||||
123830893 | 12383089 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123830893 | 12383089 | 1 | Pulmonary arterial hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123830893 | 12383089 | DE |
123830893 | 12383089 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123830893 | 12383089 | Dyspnoea | |
123830893 | 12383089 | Fluid retention | |
123830893 | 12383089 | Headache | |
123830893 | 12383089 | Pain in jaw | |
123830893 | 12383089 | Pulmonary arterial hypertension | |
123830893 | 12383089 | Urine output decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123830893 | 12383089 | 1 | 2007 | 20160606 | 0 |